oxazolidin-2-one has been researched along with Thrombosis in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Herwald, H | 1 |
| Chen, X; Chu, W; Ding, S; Gong, G; Guo, B; Sun, P; Wang, H; Wang, Y; Xue, T; Yang, Y; Zhou, Y | 1 |
| Campbell, RA; Franks, Z; Holloway, JT; Kraemer, BF; Marvin, JE; Rondina, MT; Vieira de Abreu, A; Weyrich, AS; Zimmerman, GA | 1 |
3 other study(ies) available for oxazolidin-2-one and Thrombosis
| Article | Year |
|---|---|
Anti-inflammatory, anti-coagulant, anti-biotic?
Topics: Acetamides; Animals; Anti-Bacterial Agents; Humans; Inflammation; Linezolid; Methicillin-Resistant Staphylococcus aureus; Oxazolidinones; Sepsis; Staphylococcal Infections; Thrombosis; Vancomycin | 2013 |
Design, synthesis, and structure-activity and structure-pharmacokinetic relationship studies of novel [6,6,5] tricyclic fused oxazolidinones leading to the discovery of a potent, selective, and orally bioavailable FXa inhibitor.
Topics: Administration, Oral; Animals; Biological Availability; Blood Coagulation; Chemistry Techniques, Synthetic; Drug Design; Factor Xa; Factor Xa Inhibitors; Oxazolidinones; Rats; Structure-Activity Relationship; Thrombosis | 2014 |
Methicillin-resistant Staphylococcus aureus-induced thrombo-inflammatory response is reduced with timely antibiotic administration.
Topics: Acetamides; Animals; Anti-Bacterial Agents; Blood Coagulation; Cell-Derived Microparticles; Cytokines; Drug Administration Schedule; Humans; Inflammation; Inflammation Mediators; Linezolid; Methicillin-Resistant Staphylococcus aureus; Mice; Mice, Inbred C57BL; Monocytes; Oxazolidinones; Sepsis; Staphylococcal Infections; Thrombin; Thrombosis; Time Factors; Vancomycin | 2013 |